Global Alcohol Addiction Therapeutics Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Alcohol Addiction Therapeutics market report explains the definition, types, applications, major countries, and major players of the Alcohol Addiction Therapeutics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Bionex Pharmaceuticals LLC

    • Omeros Corp

    • Ethypharm SA

    • Chronos Therapeutics Ltd

    • Cerecor Inc

    • Indivior Plc

    • Lohocla Research Corp

    • Montisera Ltd

    • Kyorin Pharmaceutical Co Ltd

    • AstraZeneca Plc

    • Curemark LLC

    • H Lundbeck A/S

    • Corcept Therapeutics Inc

    • BioCorRx Inc

    • Kinnov Therapeutics SAS

    • Eli Lilly and Company

    • Opiant Pharmaceuticals Inc

    • Heptares Therapeutics Ltd

    By Type:

    • CM-1212

    • CTDP-002

    • A-705253

    • ABT-436

    • ADX-71441

    • Others

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Alcohol Addiction Therapeutics Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Alcohol Addiction Therapeutics Outlook to 2028- Original Forecasts

    • 2.2 Alcohol Addiction Therapeutics Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Alcohol Addiction Therapeutics Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Alcohol Addiction Therapeutics Market- Recent Developments

    • 6.1 Alcohol Addiction Therapeutics Market News and Developments

    • 6.2 Alcohol Addiction Therapeutics Market Deals Landscape

    7 Alcohol Addiction Therapeutics Raw Materials and Cost Structure Analysis

    • 7.1 Alcohol Addiction Therapeutics Key Raw Materials

    • 7.2 Alcohol Addiction Therapeutics Price Trend of Key Raw Materials

    • 7.3 Alcohol Addiction Therapeutics Key Suppliers of Raw Materials

    • 7.4 Alcohol Addiction Therapeutics Market Concentration Rate of Raw Materials

    • 7.5 Alcohol Addiction Therapeutics Cost Structure Analysis

      • 7.5.1 Alcohol Addiction Therapeutics Raw Materials Analysis

      • 7.5.2 Alcohol Addiction Therapeutics Labor Cost Analysis

      • 7.5.3 Alcohol Addiction Therapeutics Manufacturing Expenses Analysis

    8 Global Alcohol Addiction Therapeutics Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Alcohol Addiction Therapeutics Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Alcohol Addiction Therapeutics Export by Region (Top 10 Countries) (2017-2028)

    9 Global Alcohol Addiction Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Alcohol Addiction Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global CM-1212 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global CTDP-002 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global A-705253 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global ABT-436 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global ADX-71441 Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Alcohol Addiction Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Alcohol Addiction Therapeutics Market Analysis and Outlook till 2022

    • 10.1 Global Alcohol Addiction Therapeutics Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.2.2 Canada Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.2.3 Mexico Alcohol Addiction Therapeutics Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.3.2 UK Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.3.3 Spain Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.3.4 Belgium Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.3.5 France Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.3.6 Italy Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.3.7 Denmark Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.3.8 Finland Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.3.9 Norway Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.3.10 Sweden Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.3.11 Poland Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.3.12 Russia Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.3.13 Turkey Alcohol Addiction Therapeutics Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.4.2 Japan Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.4.3 India Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.4.4 South Korea Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.4.5 Pakistan Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.4.6 Bangladesh Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.4.7 Indonesia Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.4.8 Thailand Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.4.9 Singapore Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.4.10 Malaysia Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.4.11 Philippines Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.4.12 Vietnam Alcohol Addiction Therapeutics Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.5.2 Colombia Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.5.3 Chile Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.5.4 Argentina Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.5.5 Venezuela Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.5.6 Peru Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.5.7 Puerto Rico Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.5.8 Ecuador Alcohol Addiction Therapeutics Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.6.2 Kuwait Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.6.3 Oman Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.6.4 Qatar Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Alcohol Addiction Therapeutics Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.7.2 South Africa Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.7.3 Egypt Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.7.4 Algeria Alcohol Addiction Therapeutics Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Alcohol Addiction Therapeutics Consumption (2017-2022)

      • 10.8.2 New Zealand Alcohol Addiction Therapeutics Consumption (2017-2022)

    11 Global Alcohol Addiction Therapeutics Competitive Analysis

    • 11.1 Bionex Pharmaceuticals LLC

      • 11.1.1 Bionex Pharmaceuticals LLC Company Details

      • 11.1.2 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Main Business and Markets Served

      • 11.1.4 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Omeros Corp

      • 11.2.1 Omeros Corp Company Details

      • 11.2.2 Omeros Corp Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Omeros Corp Alcohol Addiction Therapeutics Main Business and Markets Served

      • 11.2.4 Omeros Corp Alcohol Addiction Therapeutics Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Ethypharm SA

      • 11.3.1 Ethypharm SA Company Details

      • 11.3.2 Ethypharm SA Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Ethypharm SA Alcohol Addiction Therapeutics Main Business and Markets Served

      • 11.3.4 Ethypharm SA Alcohol Addiction Therapeutics Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Chronos Therapeutics Ltd

      • 11.4.1 Chronos Therapeutics Ltd Company Details

      • 11.4.2 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Main Business and Markets Served

      • 11.4.4 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Cerecor Inc

      • 11.5.1 Cerecor Inc Company Details

      • 11.5.2 Cerecor Inc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Cerecor Inc Alcohol Addiction Therapeutics Main Business and Markets Served

      • 11.5.4 Cerecor Inc Alcohol Addiction Therapeutics Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Indivior Plc

      • 11.6.1 Indivior Plc Company Details

      • 11.6.2 Indivior Plc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Indivior Plc Alcohol Addiction Therapeutics Main Business and Markets Served

      • 11.6.4 Indivior Plc Alcohol Addiction Therapeutics Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Lohocla Research Corp

      • 11.7.1 Lohocla Research Corp Company Details

      • 11.7.2 Lohocla Research Corp Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Lohocla Research Corp Alcohol Addiction Therapeutics Main Business and Markets Served

      • 11.7.4 Lohocla Research Corp Alcohol Addiction Therapeutics Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Montisera Ltd

      • 11.8.1 Montisera Ltd Company Details

      • 11.8.2 Montisera Ltd Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Montisera Ltd Alcohol Addiction Therapeutics Main Business and Markets Served

      • 11.8.4 Montisera Ltd Alcohol Addiction Therapeutics Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Kyorin Pharmaceutical Co Ltd

      • 11.9.1 Kyorin Pharmaceutical Co Ltd Company Details

      • 11.9.2 Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Main Business and Markets Served

      • 11.9.4 Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 AstraZeneca Plc

      • 11.10.1 AstraZeneca Plc Company Details

      • 11.10.2 AstraZeneca Plc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 AstraZeneca Plc Alcohol Addiction Therapeutics Main Business and Markets Served

      • 11.10.4 AstraZeneca Plc Alcohol Addiction Therapeutics Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Curemark LLC

      • 11.11.1 Curemark LLC Company Details

      • 11.11.2 Curemark LLC Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Curemark LLC Alcohol Addiction Therapeutics Main Business and Markets Served

      • 11.11.4 Curemark LLC Alcohol Addiction Therapeutics Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 H Lundbeck A/S

      • 11.12.1 H Lundbeck A/S Company Details

      • 11.12.2 H Lundbeck A/S Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 H Lundbeck A/S Alcohol Addiction Therapeutics Main Business and Markets Served

      • 11.12.4 H Lundbeck A/S Alcohol Addiction Therapeutics Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Corcept Therapeutics Inc

      • 11.13.1 Corcept Therapeutics Inc Company Details

      • 11.13.2 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Main Business and Markets Served

      • 11.13.4 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 BioCorRx Inc

      • 11.14.1 BioCorRx Inc Company Details

      • 11.14.2 BioCorRx Inc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 BioCorRx Inc Alcohol Addiction Therapeutics Main Business and Markets Served

      • 11.14.4 BioCorRx Inc Alcohol Addiction Therapeutics Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Kinnov Therapeutics SAS

      • 11.15.1 Kinnov Therapeutics SAS Company Details

      • 11.15.2 Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Main Business and Markets Served

      • 11.15.4 Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 Eli Lilly and Company

      • 11.16.1 Eli Lilly and Company Company Details

      • 11.16.2 Eli Lilly and Company Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 Eli Lilly and Company Alcohol Addiction Therapeutics Main Business and Markets Served

      • 11.16.4 Eli Lilly and Company Alcohol Addiction Therapeutics Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    • 11.17 Opiant Pharmaceuticals Inc

      • 11.17.1 Opiant Pharmaceuticals Inc Company Details

      • 11.17.2 Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.17.3 Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Main Business and Markets Served

      • 11.17.4 Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Product Portfolio

      • 11.17.5 Recent Research and Development Strategies

    • 11.18 Heptares Therapeutics Ltd

      • 11.18.1 Heptares Therapeutics Ltd Company Details

      • 11.18.2 Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.18.3 Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Main Business and Markets Served

      • 11.18.4 Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Product Portfolio

      • 11.18.5 Recent Research and Development Strategies

    12 Global Alcohol Addiction Therapeutics Market Outlook by Types and Applications to 2028

    • 12.1 Global Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global CM-1212 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global CTDP-002 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global A-705253 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global ABT-436 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global ADX-71441 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Alcohol Addiction Therapeutics Market Analysis and Outlook to 2028

    • 13.1 Global Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.2.2 Canada Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.3.2 UK Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.3.3 Spain Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.3.5 France Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.3.6 Italy Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.3.8 Finland Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.3.9 Norway Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.3.11 Poland Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.3.12 Russia Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.4.2 Japan Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.4.3 India Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.5.3 Chile Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.5.6 Peru Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.6.3 Oman Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Alcohol Addiction Therapeutics

    • Figure of Alcohol Addiction Therapeutics Picture

    • Table Global Alcohol Addiction Therapeutics Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Alcohol Addiction Therapeutics Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global CM-1212 Consumption and Growth Rate (2017-2022)

    • Figure Global CTDP-002 Consumption and Growth Rate (2017-2022)

    • Figure Global A-705253 Consumption and Growth Rate (2017-2022)

    • Figure Global ABT-436 Consumption and Growth Rate (2017-2022)

    • Figure Global ADX-71441 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Alcohol Addiction Therapeutics Consumption by Country (2017-2022)

    • Table North America Alcohol Addiction Therapeutics Consumption by Country (2017-2022)

    • Figure United States Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Canada Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Mexico Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Alcohol Addiction Therapeutics Consumption by Country (2017-2022)

    • Figure Germany Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure UK Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Spain Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Belgium Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure France Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Italy Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Denmark Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Finland Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Norway Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Sweden Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Poland Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Russia Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Turkey Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Table APAC Alcohol Addiction Therapeutics Consumption by Country (2017-2022)

    • Figure China Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Thailand Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Singapore Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Philippines Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Table South America Alcohol Addiction Therapeutics Consumption by Country (2017-2022)

    • Figure Brazil Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Colombia Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Chile Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Argentina Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Peru Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Table GCC Alcohol Addiction Therapeutics Consumption by Country (2017-2022)

    • Figure Bahrain Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Oman Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Qatar Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Africa Alcohol Addiction Therapeutics Consumption by Country (2017-2022)

    • Figure Nigeria Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Africa Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Egypt Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Algeria Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Oceania Alcohol Addiction Therapeutics Consumption by Country (2017-2022)

    • Figure Australia Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Bionex Pharmaceuticals LLC Company Details

    • Table Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Main Business and Markets Served

    • Table Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Product Portfolio

    • Table Omeros Corp Company Details

    • Table Omeros Corp Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Omeros Corp Alcohol Addiction Therapeutics Main Business and Markets Served

    • Table Omeros Corp Alcohol Addiction Therapeutics Product Portfolio

    • Table Ethypharm SA Company Details

    • Table Ethypharm SA Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ethypharm SA Alcohol Addiction Therapeutics Main Business and Markets Served

    • Table Ethypharm SA Alcohol Addiction Therapeutics Product Portfolio

    • Table Chronos Therapeutics Ltd Company Details

    • Table Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Main Business and Markets Served

    • Table Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Product Portfolio

    • Table Cerecor Inc Company Details

    • Table Cerecor Inc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cerecor Inc Alcohol Addiction Therapeutics Main Business and Markets Served

    • Table Cerecor Inc Alcohol Addiction Therapeutics Product Portfolio

    • Table Indivior Plc Company Details

    • Table Indivior Plc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Indivior Plc Alcohol Addiction Therapeutics Main Business and Markets Served

    • Table Indivior Plc Alcohol Addiction Therapeutics Product Portfolio

    • Table Lohocla Research Corp Company Details

    • Table Lohocla Research Corp Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lohocla Research Corp Alcohol Addiction Therapeutics Main Business and Markets Served

    • Table Lohocla Research Corp Alcohol Addiction Therapeutics Product Portfolio

    • Table Montisera Ltd Company Details

    • Table Montisera Ltd Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Montisera Ltd Alcohol Addiction Therapeutics Main Business and Markets Served

    • Table Montisera Ltd Alcohol Addiction Therapeutics Product Portfolio

    • Table Kyorin Pharmaceutical Co Ltd Company Details

    • Table Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Main Business and Markets Served

    • Table Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Product Portfolio

    • Table AstraZeneca Plc Company Details

    • Table AstraZeneca Plc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Plc Alcohol Addiction Therapeutics Main Business and Markets Served

    • Table AstraZeneca Plc Alcohol Addiction Therapeutics Product Portfolio

    • Table Curemark LLC Company Details

    • Table Curemark LLC Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Curemark LLC Alcohol Addiction Therapeutics Main Business and Markets Served

    • Table Curemark LLC Alcohol Addiction Therapeutics Product Portfolio

    • Table H Lundbeck A/S Company Details

    • Table H Lundbeck A/S Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table H Lundbeck A/S Alcohol Addiction Therapeutics Main Business and Markets Served

    • Table H Lundbeck A/S Alcohol Addiction Therapeutics Product Portfolio

    • Table Corcept Therapeutics Inc Company Details

    • Table Corcept Therapeutics Inc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Corcept Therapeutics Inc Alcohol Addiction Therapeutics Main Business and Markets Served

    • Table Corcept Therapeutics Inc Alcohol Addiction Therapeutics Product Portfolio

    • Table BioCorRx Inc Company Details

    • Table BioCorRx Inc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioCorRx Inc Alcohol Addiction Therapeutics Main Business and Markets Served

    • Table BioCorRx Inc Alcohol Addiction Therapeutics Product Portfolio

    • Table Kinnov Therapeutics SAS Company Details

    • Table Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Main Business and Markets Served

    • Table Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Product Portfolio

    • Table Eli Lilly and Company Company Details

    • Table Eli Lilly and Company Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company Alcohol Addiction Therapeutics Main Business and Markets Served

    • Table Eli Lilly and Company Alcohol Addiction Therapeutics Product Portfolio

    • Table Opiant Pharmaceuticals Inc Company Details

    • Table Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Main Business and Markets Served

    • Table Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Product Portfolio

    • Table Heptares Therapeutics Ltd Company Details

    • Table Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Main Business and Markets Served

    • Table Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Product Portfolio

    • Figure Global CM-1212 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CTDP-002 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global A-705253 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ABT-436 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ADX-71441 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alcohol Addiction Therapeutics Consumption Forecast by Country (2022-2028)

    • Table North America Alcohol Addiction Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Alcohol Addiction Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure Germany Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Alcohol Addiction Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure China Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Alcohol Addiction Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure Brazil Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Alcohol Addiction Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Alcohol Addiction Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Alcohol Addiction Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure Australia Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.